The layoffs are the latest indication of Health Secretary Robert F. Kennedy Jr.’s drastic effort to completely remake the nation’s public health infrastructure.

Cellares' forward momentum continues, as the company announced April 1, 2025, a notable milestone for its Cell Shuttle.

We are excited to welcome Steve to Phathom during this important growth period for our Company,” said Michael Cola, Chairman of Phathom. “Steve is an accomplished biopharmaceutical leader with a ...

Eli Lilly is suing Strive Pharmacy and Empower Pharmacy for compounding tirzepatide, the active ingredient in Zepbound and ...

Photobiomodulation Therapy (PBMT) uses red and near-infrared light to enhance cellular repair, reduce inflammation, and support neurological and skin health. Learn how it works, how it's different ...

When a critically injured patient is admitted to the hospital, how much supplemental oxygen should they receive? New research published this week in JAMA Network Open led by investigators at the ...

Novo Nordisk already has broad FDA approvals in hand for its injected semaglutide products Ozempic and Wegovy to reduce the ...

Soleno Therapeutics (SLNO) stock skyrocketed up over 42% this past week on news that it has achieved a significant milestone with FDA approval ...

The top vaccine official with the Food and Drug Administration has resigned and criticized the nation's top health official ...

Sanofi’s treatment for hemophilia that can be administered as infrequently as once every other month, was approved by the US ...

Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of ...